The US Supreme Court has again turned to the issue of proper venue for lawsuits – one that has been brought to a head by the challenging of decisions on e-cigarette authorisations by the US Food and Drug Administration (FDA).
The issue has been raised several times in lawsuits by companies disgruntled with the marketing denial orders (MDOs) they have been issued by the FDA as part of its premarket tobacco product application (PMTA) process.
